Multiple Scedosporium apiospermum abscesses in a woman survivor of a tsunami in northeastern Japan: A case report

Journal of Medical Case Reports

Volumn 5, Issue , 2011, Pages

  Nakamura, Yutaka ^a   Utsumi, Yu ^a   Suzuki, Naomi ^a   Nakajima, Yoshio ^a   Murata, Okinori ^a   Sasaki, Nobuhito ^a   Nitanai, Hiroo ^a   Nagashima, Hiromi ^b   Miyamoto, Shinya ^b   Yaegashi, Jun ^c   Hatakeyama, Tomoki ^c   Shibano, Yoshihiro ^c   Yarita, Kyoko ^d   Kamei, Katsuhiko ^d   Nakadate, Toshihide ^a   Endo, Shigeatsu ^a   Terayama, Yasuo ^a   Yamauchi, Kohei ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Iwate Prefectural Miyako Hospital   (Japan)

^c Saiseikai Iwaizumi Hospital   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; MICAFUNGIN; VORICONAZOLE;

ADULT; ARTICLE; ASPERGILLOSIS; BRAIN ABSCESS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; FEMALE; FUNGUS CULTURE; HEART VENTRICLE EXTRASYSTOLE; HUMAN; JAPAN; LOW DRUG DOSE; LUNG ABSCESS; LUNG LAVAGE; NEAR DROWNING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSEUDALLESCHERIASIS; SCEDOSPORIUM APIOSPERMUM; THORAX SCINTISCANNING; TSUNAMI;

EID: 80054856702     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-5-526     Document Type: Article

References (15)

1. Near-drowning complicated by brain abscess due to Petriellidium boydii. Fisher JF, Shadomy S, Teabeaut JR, Woodward J, Michaels GE, Newman MA, White E, Cook P, Seagraves A, Yaghmai F, Rissing JP, Arch Neurol 1982 39 511 513 7103801 (Pubitemid 12089654)
2. Pseudallescheria boydii and brain abscesses. Hachimi-Idrissi S, Willemsen M, Desprechins B, Naessens A, Goossens A, De Meirleir L, Ramet J, Pediatr Infect Dis J 1990 9 737 741 10.1097/00006454-199010000-00011 2235148 (Pubitemid 20335447)
3. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, Just-Nübling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E, Clin Infect Dis 2003 36 1122 1131 10.1086/374557 12715306 (Pubitemid 36549632)
4. The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis. Schwartz S, Reisman A, Troke PF, Infection 2011 39 201 210 10.1007/s15010-011-0108-6 21512792
5. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole phase III clinical studies. Espinel-Ingroff A, Johnson E, Hockey H, Troke P, J Antimicrob Chemother 2008 61 616 620 10.1093/jac/dkm518 18222957 (Pubitemid 351321136)
6. Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman. Elter T, Sieniawski M, Gossmann A, Wickenhauser C, Schröder U, Seifert H, Kuchta J, Burhenne J, Riedel KD, Fätkenheuer G, Cornely OA, Int J Antimicrob Agents 2006 28 262 265 10.1016/j.ijantimicag.2006.04.006 16908120 (Pubitemid 44223976)
7. Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study. Lazarus HM, Blumer JL, Yanovich S, Schlamm H, Romero A, J Clin Pharmacol 2002 42 395 402 10.1177/0091270002424005 11936564 (Pubitemid 34259773)
8. Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities. Tan K, Brayshaw N, Tomaszewski K, Troke P, Wood N, J Clin Pharmacol 2006 46 235 243 10.1177/0091270005283837 16432276 (Pubitemid 43146453)
9. Inherited long QT syndrome revealed by antifungals drug-drug interaction. Eiden C, Peyrière H, Tichit R, Cociglio M, Amedro P, Blayac JP, Margueritte G, Hillaire-Buys D, J Clin Pharm Ther 2007 32 321 324 10.1111/j.1365-2710.2007.00812.x 17489884 (Pubitemid 46699512)
10. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Meletiadis J, Meis JF, Mouton JW, Rodriquez-Tudela JL, Donnelly JP, Verweij PE, EUROFUNG Network, Antimicrob Agents Chemother 2002 46 62 68 10.1128/AAC.46.1.62-68.2002 11751112 (Pubitemid 34031603)
11. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL, Antimicrob Agents Chemother 2006 50 917 921 10.1128/AAC.50.3.917-921.2006 16495251 (Pubitemid 43327795)
12. Scedosporium apiospermum infection after near-drowning. Katragkou A, Dotis J, Kotsiou M, Tamiolaki M, Roilides E, Mycoses 2007 50 412 421 10.1111/j.1439-0507.2007.01388.x 17714363 (Pubitemid 47256295)
13. Treatment of Scedosporiosis with voriconazole: clinical experience with 107 patients. Troke P, Aguirrebengoa K, Arteaga C, Ellis D, Heath CH, Lutsar I, Rovira M, Nguyen Q, Slavin M, Chen SC, Global Scedosporium Study Group, Antimicrob Agents Chemother 2008 52 1743 1750 10.1128/AAC.01811-10 21576441 (Pubitemid 351614668)
14. Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii. Walsh TJ, Peter J, McGough DA, Fothergill AW, Rinaldi MG, Pizzo PA, Antimicrob Agents Chemother 1995 39 1361 1364 7574531
15. Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans. Rodríguez MM, Calvo E, Serena C, Mariné M, Pastor FJ, Guarro J, Antimicrob Agents Chemother 2009 53 2153 2155 10.1128/AAC.01477-08 19223617